Large Animal Revivon Solution for Injection

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Large Animal Revivon Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient:
mg/ml
Diprenorphine
3.0
(as Diprenorphine hydrochloride
3.26)
Preservative:
Chlorocresol
1.0
Colouring Agent:
Methylthioninium chloride
0.1
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear blue aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses and deer.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
To reverse neuroleptanalgesia induced by etorphine hydrochloride.
4.3
CONTRAINDICATIONS
Do not use intramuscularly except in the circumstances of an emergency
where
intravenous injection is not possible.
Do not dilute or mix with any other substances.
Do not use in animals intended for animal consumption.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Animals MUST be kept stabled, protected from extremes of temperature
and under
close supervision for at least 24 hours, particularly for the first 8
hours following
administration.
Care must be taken to avoid hypothermia or hyperthermia (see above).
Protect horses eyes from sun or bright light following administration.
4.5
Special precautions for use
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
II)
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Spillages should be dealt with AFTER PUTTING ON SUITABLE HEAVY DUTY
RUBBER GLOVES, neoprene or nitrile of minimum thickness 0.5 mm, using
a
copious quantity of water, which can then be flushed down a running
sink. Broken
glass should be washed and disposed of in a recognised manner.
The product may induce a hallucinatory state after accidental
self-administration.
TO AVOID ACCIDENTAL SELF-INJECTION, the following procedure should be
adopted:
(a)
Use two sterile needles, one to fill the syringe from the vial and one
to inject the
patient. Once the required dose has been withdrawn from the vial, the
syringe
sho
                                
                                Read the complete document